Antisense therapy in clinical oncology: Preclinical and clinical experiences

ISSN： 1073-6085

Source： Molecular Biotechnology, Vol.33, Iss.3, 2006-07, pp. : 221-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical and clinical pharmacology of antisense oligonucleotides

By Marcusson E. Yacyshyn B. Shanahan W. Dean N.

Molecular Biotechnology, Vol. 12, Iss. 1, 1999-08 ,pp. : 1-11

Humana Press, Inc

Access to resources Recommend Favorite

Antisense oligonucleotides: towards clinical trials

By Agrawal S.

Trends in Biotechnology, Vol. 14, Iss. 10, 1996-10 ,pp. : 376-387

Elsevier

Access to resources Recommend Favorite

The conundrum between immunological memory to adenovirus and their use as vectors in clinical gene therapy

By Perreau Matthieu Kremer E.

Molecular Biotechnology, Vol. 34, Iss. 2, 2006-10 ,pp. : 247-256

Humana Press, Inc

Access to resources Recommend Favorite

Standardising clinical data elements

By Nahm Meredith

International Journal of Functional Informatics and Personalised Medicine, Vol. 3, Iss. 4, 2010-05 ,pp. : 314-341

Inderscience Publishers

Access to resources Recommend Favorite

Application of stains in clinical microbiology

By Madison BM

Biotechnic & Histochemistry, Vol. 76, Iss. 3, 2001-05 ,pp. : 119-125

Informa Healthcare

Access to resources Recommend Favorite